Wolf AM - Search Results

1

Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma.

Steiner N, Göbel G, Michaeler D, Platz AL, Prokop W, Wolf AM, Wolf D, Duftner C, Gunsilius E. Steiner N, et al. Among authors: wolf d, wolf am. Blood Adv. 2021 Mar 23;5(6):1746-1754. doi: 10.1182/bloodadvances.2020003193. Blood Adv. 2021. PMID: 33749761 Free PMC article.

2

Mesenchymal stem cells as cellular immunosuppressants.

Wolf D, Wolf AM. Wolf D, et al. Among authors: wolf am. Lancet. 2008 May 10;371(9624):1553-4. doi: 10.1016/S0140-6736(08)60666-2. Lancet. 2008. PMID: 18468526 No abstract available.

3

CCR 20th Anniversary Commentary: From Regulatory T Cells to Checkpoint Monoclonal Antibodies--Immuno-oncology Advances Clinical Cancer Research.

Wolf D, Wolf AM. Wolf D, et al. Among authors: wolf am. Clin Cancer Res. 2015 Jun 15;21(12):2657-9. doi: 10.1158/1078-0432.CCR-14-2558. Clin Cancer Res. 2015. PMID: 26078428

4

RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines.

Rumpold H, Wolf AM, Gruenewald K, Gastl G, Gunsilius E, Wolf D. Rumpold H, et al. Among authors: wolf d, wolf am. Exp Hematol. 2005 Jul;33(7):767-75. doi: 10.1016/j.exphem.2005.03.014. Exp Hematol. 2005. PMID: 15963852 Free article.

5

CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.

Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H, Mayer G, Gunsilius E, Rosenkranz AR. Wolf D, et al. Among authors: wolf am. J Am Soc Nephrol. 2005 May;16(5):1360-70. doi: 10.1681/ASN.2004100837. Epub 2005 Mar 23. J Am Soc Nephrol. 2005. PMID: 15788479

6

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E, Marth C. Wolf D, et al. Among authors: wolf am. Clin Cancer Res. 2005 Dec 1;11(23):8326-31. doi: 10.1158/1078-0432.CCR-05-1244. Clin Cancer Res. 2005. PMID: 16322292

7

The effect of zoledronic acid on the function and differentiation of myeloid cells.

Wolf AM, Rumpold H, Tilg H, Gastl G, Gunsilius E, Wolf D. Wolf AM, et al. Among authors: wolf d. Haematologica. 2006 Sep;91(9):1165-71. Haematologica. 2006. PMID: 16956814

8

Novel treatment concepts for graft-versus-host disease.

Wolf D, von Lilienfeld-Toal M, Wolf AM, Schleuning M, von Bergwelt-Baildon M, Held SA, Brossart P. Wolf D, et al. Among authors: wolf am. Blood. 2012 Jan 5;119(1):16-25. doi: 10.1182/blood-2011-08-339465. Epub 2011 Sep 26. Blood. 2012. PMID: 21948301 Free article. Review.

9

Regulatory T cells in cancer biology: a possible new target for biochemical therapies.

Wolf D, Rumpold H, Wolf AM. Wolf D, et al. Among authors: wolf am. Mini Rev Med Chem. 2006 May;6(5):509-13. doi: 10.2174/138955706776876230. Mini Rev Med Chem. 2006. PMID: 16719824 Review.

10

Treg(s) in Cancer: Friends or Foe?

Wolf D, Sopper S, Pircher A, Gastl G, Wolf AM. Wolf D, et al. Among authors: wolf am. J Cell Physiol. 2015 Nov;230(11):2598-605. doi: 10.1002/jcp.25016. J Cell Physiol. 2015. PMID: 25913194 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page